Headquarters: Tel Aviv, Israel
Investor Relations: Greg Chodaczek / Gilmartin Group / email@example.com / 347-620-7010
Memic has set out to transform robotic-assisted surgery, with proprietary technology that has the potential to far surpass today’s best solutions. Providing unprecedented access and maneuverability, our Memic’s Hominis® surgical platform features miniature, humanoid-shaped robotic arms with human dexterity, superhuman flexibility, and 360˚ articulation. In addition to these features, the system will be sold at a significantly lower price compared to other marketed robotic surgery systems potentially allowing more medical facilities including hospitals and ambulatory surgical centers to access and adopt surgical robotics. Beyond the current applications for transvaginal procedures, Memic is further developing this technology to explore use in abdominal single and multi-port surgery, as well as other transluminal indications.